Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pronzato

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2007
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) GroupL Del Mastro, B Dozin, E Aitini, et al.
Breast (Edinburgh, Scotland)|April 1, 2017
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysisF Poggio, M Ceppi, M Lambertini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancerB Banelli, I Casciano, A Di Vinci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studiesM Lambertini, M Ceppi, F Poggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancerM Venturini, A Michelotti, L Del Mastro, et al.
ESMO Open|February 15, 2023
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literatureA Boutros, A Bottini, G Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2018
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡P Conte, A Frassoldati, G Bisagni, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2007
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) GroupL Del Mastro, B Dozin, E Aitini, et al.
Breast (Edinburgh, Scotland)|April 1, 2017
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysisF Poggio, M Ceppi, M Lambertini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancerB Banelli, I Casciano, A Di Vinci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studiesM Lambertini, M Ceppi, F Poggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancerM Venturini, A Michelotti, L Del Mastro, et al.
ESMO Open|February 15, 2023
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literatureA Boutros, A Bottini, G Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2018
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡P Conte, A Frassoldati, G Bisagni, et al.
Pageof 13